Table 2.
COPDGene | SPIROMICS | Combined | |||||
---|---|---|---|---|---|---|---|
Biomarker | ß | R2 (adj) | P | ß | R2 (adj) | P | P |
Eotaxin | −12.2 | 0.007 | 0.0001 | −31.3 | 0.039 | < 10−10 | < 10−12 |
CCL26 | −1.7 | 0.000 | 0.2225 | −3.4 | 0.001 | 0.1095 | 0.0679 |
CCL17 | 0.1 | 0.000 | 0.9383 | −3.7 | 0.001 | 0.1664 | 0.3525 |
IFN-γ | −6.2 | 0.006 | 0.0003 | −4.5 | 0.002 | 0.0881 | 0.0002 |
IL10 | −4.1 | 0.003 | 0.0072 | −6.2 | 0.003 | 0.0442 | 0.0013 |
IL2 | −2.8 | 0.002 | 0.0426 | −7.2 | 0.007 | 0.0043 | 0.0016 |
IL6 | −16.2 | 0.049 | < 10−23 | −21.1 | 0.042 | < 10−11 | < 10−34 |
IL8 | −4.2 | 0.002 | 0.0226 | −9.9 | 0.005 | 0.0091 | 0.0008 |
TNF-α | −7.0 | 0.006 | 0.0004 | −6.4 | 0.001 | 0.1725 | 0.0003 |
R2 (adj) is the partial amount of variance explained by the biomarker in models with clinical covariates